8.56
3.38%
0.28
전일 마감가:
$8.28
열려 있는:
$8.36
하루 거래량:
261.27K
Relative Volume:
0.46
시가총액:
$527.03M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-11.73
EPS:
-0.73
순현금흐름:
$-41.50M
1주 성능:
+7.27%
1개월 성능:
+82.52%
6개월 성능:
+65.89%
1년 성능:
-3.06%
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
8.56 | 527.03M | 198.53M | -63.68M | -41.50M | -0.73 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
2023-09-29 | 개시 | UBS | Buy |
2023-05-01 | 개시 | Truist | Buy |
2023-04-11 | 개시 | Stephens | Equal-Weight |
2022-05-12 | 개시 | BTIG Research | Buy |
2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2021-05-18 | 개시 | JP Morgan | Overweight |
2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
2021-05-18 | 개시 | SVB Leerink | Outperform |
2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times
Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com
Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks
Morgan Stanley's Strategic Reduction in Treace Medical Concepts Inc. - GuruFocus.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue - Investing.com India
U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn
Treace Medical (TMCI) Experiences Stock Boost After Reporting Strong Results - Stocks Telegraph
Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Treace Medical Concepts: Q3 Earnings Snapshot - San Francisco Chronicle
Treace Medical Concepts Reports Third Quarter 2024 Financial Results - The Manila Times
Vanguard Group Inc's Strategic Reduction in Treace Medical Conce - GuruFocus.com
Treace Announces Participation in the UBS Global Healthcare Conference - The Manila Times
Earnings Preview For Treace Medical Concepts - Benzinga
Treace Comments on CMS' 2025 Final Rule for Hospital Outpatient and ASC Settings - The Manila Times
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings - StockTitan
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure - The Manila Times
Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.00 Consensus PT from Brokerages - Defense World
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Reviewing Treace Medical Concepts (NASDAQ:TMCI) & BrainsWay (NASDAQ:BWAY) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Treace Medical Concepts (TMCI) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on - The Bakersfield Californian
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way? - Simply Wall St
SG Americas Securities LLC Purchases Shares of 23,591 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Bleakley Financial Group LLC Cuts Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 - ForexTV.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - Benzinga
The Manufacturers Life Insurance Company Increases Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology - ForexTV.com
Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion ... - Post Register
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):